Name: STA-Liquid Anti-Xa
Rating: 3 (18 reviews)

报价请求

Stago offers a comprehensive range for anticoagulant monitoring. STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH, fondaparinux, apixaban, rivaroxaban, edoxaban testing.
It is based on the inhibition of a known amount of factor Xa by the patient's sample heparin/DOAC. The residual factor Xa activity assessed by a colorimetric test will be inversely proportional to the heparin/DOAC concentration.
STA®-Liquid Anti-Xa main features are summarised in the table below:
<table>
<tr>
<th>
Features
</th>
<th>
Advantages
</th>
<th>
Benefits
</th>
</tr>
<tr>
<td>
Liquid format:
4 & 8 mL
</td>
<td>
·  Ready-to-use: no reconstitution steps
</td>
<td>
·  Reduced handling time: always available
·  No waste of reagent: budget is optimized.
</td>
</tr>
<tr>
<td>
Working range: UFH: 0.1 to 1.1 IU/mL LMWH: 0.1 to 2.0 IU Anti-Xa/mL FDX: 0.1 to 2.0 µg/mL
</td>
<td>
·  No re-dilutions ·  Allows to detect accumulation
</td>
<td>
·  User-friendly & secure: no analytical mistake
</td>
</tr>
<tr>
<td>
Calibration: Dedicated and hybrid calibrations
</td>
<td>
·  "The choice is yours" ·  Ease stock management: only 1 reference.
</td>
<td>
·  Total flexibility ·  Cost effective
</td>
</tr>
<tr>
<td>
 QC levels: UFH: 0.2 & 0.7 IU/mL LMWH: 0.8 & 1.4 IU Anti-Xa /mL
</td>
<td>
·  QC for each dose peak: represent the extreme situation
</td>
<td>
·  Secure: follow-up of system performances at the limit of therapeutic ranges 
</td>
</tr>
<tr>
<td>
 Fondaparinux, apixaban, rivaroxaban, edoxaban: Dedicated Calibration and QC kits
</td>
<td>
Comply with recommendations (manufacturer, literature)
</td>
<td>
·  User friendly & secure: eliminate risks of error
</td>
</tr>
</table>

數量

Ship to Country

Member since : 16-二月-2017

DIAGNOSTICA STAGO S.A.S

'基本成员'

去商店

报价请求

數量

Ship to Country

医学材料及配件

STA-Liquid Anti-Xa

强调 :

最低订购 : 1
條件 : New
Country of shipping :

使用 Abraa 安全交易系统进行安全可靠的支付

项目详细信息

產品規格

	Diagnostica Stago S.A.S
	New

Product Descriptions

Stago offers a comprehensive range for anticoagulant monitoring. STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH, fondaparinux, apixaban, rivaroxaban, edoxaban testing.

It is based on the inhibition of a known amount of factor Xa by the patient's sample heparin/DOAC. The residual factor Xa activity assessed by a colorimetric test will be inversely proportional to the heparin/DOAC concentration.

STA®-Liquid Anti-Xa main features are summarised in the table below:

Features	Advantages	Benefits
Liquid format: 4 & 8 mL	· Ready-to-use: no reconstitution steps	· Reduced handling time: always available · No waste of reagent: budget is optimized.
Working range: UFH: 0.1 to 1.1 IU/mL LMWH: 0.1 to 2.0 IU Anti-Xa/mL FDX: 0.1 to 2.0 µg/mL	· No re-dilutions · Allows to detect accumulation	· User-friendly & secure: no analytical mistake
Calibration: Dedicated and hybrid calibrations	· "The choice is yours" · Ease stock management: only 1 reference.	· Total flexibility · Cost effective
QC levels: UFH: 0.2 & 0.7 IU/mL LMWH: 0.8 & 1.4 IU Anti-Xa /mL	· QC for each dose peak: represent the extreme situation	· Secure: follow-up of system performances at the limit of therapeutic ranges
Fondaparinux, apixaban, rivaroxaban, edoxaban: Dedicated Calibration and QC kits	Comply with recommendations (manufacturer, literature)	· User friendly & secure: eliminate risks of error